Use of Bacillus thuringiensis var israelensis as a viable option in an Integrated Malaria Vector Control Programme in the Kumasi Metropolis, Ghana

Particle and Fibre Toxicology

Kwasi Obiri-Danso⁴  Norbert Becker³  Samuel Oppong⁴  Augustina Annan²  Sandra Baffour-Awuah⁴  Thomas Kruppa¹  Ellis Owusu-Dabo²  Rita Nartey⁴ 

[1] Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany;Kumasi Center for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;German Mosquito Control Association (KABS), Waldsee, Germany;Department of Theoretical and Applied Biology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

关键词: Ghana;    Kumasi;    Mosquito control;    Microbial larvicide;    Malaria vector;    Water dispersible granule;    Bacillus thuringiensis var israelensis;    Anopheles gambiae;   

Others  :  1227986
DOI  :  10.1186/1756-3305-6-116

 received in 2013-02-06, accepted in 2013-04-17,  发布年份 2013

【 摘 要 】

Background

Integrated Vector Control (IVC) remains the approach for managing the malaria-causing vector. The study investigated the contribution of Bacillus thuringiensis israelensis (Bti) in the control of malaria by targeting the larvae and also mapped and documented major breeding sites in the Kumasi metropolis, Ghana.

Methods

Using a hand held GPS receiver unit, major breeding sites within the metropolis were mapped out during the larval survey. Mosquito larvae were then collected from the breeding sites and reared in an insectary to obtain an F1 generation for laboratory bioassays. The minimum effective dosage of Bti Water Dispersible Granular (WDG) formulation was determined by a series of bioassays. Based on the results obtained in the laboratory, the optimum effective dosage of Bti formulations against naturally occurring larvae of the indigenous mosquito species was determined through open field trials.

Results

A total of 33 breeding sites were identified and geo-referenced during the larval surveys with the majority of the breeding sites located in the Asokwa sub-metropolis, Kumasi, Ghana. A Bti (3,000 International Toxic Unit (ITU)/mg) concentration of 0.026 mg/l resulted in 50% mortality whilst a concentration of 0.136 mg/l resulted in 95% mortality. Results from the open field trials with Bti showed that a dosage of 0.2 kg/ha is as effective as 0.4 kg/ha in suppressing late instars and resulting pupae.

Conclusion

This study reveals that Bti at a very low dosage of 0.2 kg/ha is highly effective against Anopheles larvae and therefore offers viable options for the management of vector mosquitoes. Further research is needed to extend this to the field in order to determine its ability to reduce malaria incidence.

【 授权许可】

   
2013 Nartey et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Etang J, Fondjo E: First report of knockdown mutations in the malaria vector Anopheles gambiae from Cameroon. Am J Trop Med Hyg 2006, 74:795-797.
• [2]Mittal PK: Biolarvicides in vector control: Challenges and prospects. J Vector Borne Dis 2003, 40:20-32.
• [3]Raghavendra K, Barik TK, Reddy BPN, Sharma P: Malaria vector control: From past to future. Parasitol Res 2011, 108:757-779.
• [4]Mohan DR, Ramaswamy M: Evaluation of larvicidal activity of the leaf extract of a weed plant, Ageratina adenophora, against two important species of mosquitoes, Aedes aegypti and Culex quinquefasciatus. Afr J Biotechnol 2007, 6(Suppl 5):631-638.
• [5]Becker N, Petric D, Zgomba M, Boase C, Madon M, Dahl C, Kaiser A: Mosquito and their control. 2nd edition. Heidelberg: Springer; 2010:587.
• [6]Walker K: A review of control methods for African malaria vectors; Activity report 108. Washington WA USA: Agency for International Development; 2002.
• [7]Ghana Statistical Service (GSS) (2000): Population and Housing Census –Special Report on Urban Localities. Accra: GSS; 2002.
• [8]World Health Organization: Guidelines for laboratory and field testing of mosquito larvicides. Available from: WHO/CDS/WHOPES/GCDPP/2005/13
• [9]World Health Organization: International programme on chemical safety (IPCS): microbial pest control agent Bacillus thuringiensis. Envt Health Criteria 1999, 217:1-105.
• [10]Lyimo EO, Takken W: Effects of adult body size on fecundity and the pre-gravid rate of Anopheles gambiae females in Tanzania. Med Vector Entomol 1993, 7:328-332.
• [11]Fillinger U, Knols BGJ, Becker N: Efficacy and efficiency of new Bacillus thuringiensis var. israelensis and Bacillus sphaericus formulations against Afrotropical anophelines in Western Kenya. Trop Med Int Health 2003, 8:37-47.
• [12]Karch S, Asidi N, Manzambi M, Salaun JJ: Efficacy of Bacillus sphaericus against the malaria vector Anopheles gambiae and other mosquitoes in swamps and rice fields in Zaire. J Am Mosq Control Assoc 1992, 8:376-380.
• [13]Romi R, Ravoniharimelina B, Ramiakajato M, Majori G: Field trials of Bacillus thuringiensis H-14 and Bacillus sphaericus (strain 2362) formulations against Anopheles arabiensis in the central highlands of Madagascar. J Am Mosq Control Assoc 1993, 9:325-329.
• [14]Barbazan P, Baldet T, Darriet F, Escaffre H, Haman D, Hougard JM: Control of Culex quinquefasciatus (Diptera: Culicidae) with Bacillus sphaericus in Maroua, Cameroon. J Am Mosq Control Assoc 1997, 13:263-269.
• [15]Tianyun S, Mulla MS: Field evaluation of new water-dispersible granular formulations of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquitoes in microcosms. J Am Mosq Control Assoc 1999, 15:356-365.
• [16]Schnetter W, Engler S, Morawcik J, Becker N: Wirk-mkeit von Bacillus thuringiensis var. israelensis gegen Stech- muecken und Non-Target Organismen. Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte. Entomologie 1981, 2:195-202.
• [17]Ragoonanansingh RN, Njunwa KJ, Curtis CF, Becker N: A field study of Bacillus sphaericus for the control of culicine and anopheline mosquito larvae in Tanzania. Bull Soc Vector Ecol 1992, 17:45-50.
• [18]Becker N, Rettich F: Protocol for the introduction of new Bacillus thuringiensis israelensis products into the routine mosquito control program in Germany. J Am Mosq Control Assoc 1994, 10:527-533.
• [19]SPSS Inc: SPSS Base 16.0 Windows User's Guide. Chicago, IL, USA: SPSS Inc; 2008.
• [20]Majambere S, Lindsay SW, Green C, Kandeh B, Fillinger U: Microbial larvicides for malaria control in the Gambia. Malar J 2007, 6:76. BioMed Central Full Text
• [21]Mulla MS, Norland RL, Fanara DM, Darwazeh A, McKean D: Control of chironomid midges in recreational lakes. J Econ Entomol 1971, 64:300-307.
• [22]SAS Institute Inc: SAS/STAT Version 9.2 User's Guide. Cary, NC, USA: ; 2012.
• [23]Gilles MT, de Meillon B: The Anophelines of Africa, South of the Sahara. S Afr Inst Med Res 1968, 54:1-343.
• [24]Gillies MT, Coetzee M: A supplement to the Anophelines of Africa South of the Sahara (Afrotropical region). S Afr Inst Med Res 1987, 55:1-143.
• [25]Seyoum A, Abate D: Larvicidal efficacy of Bacillus thuringiensis var. israelensis and Bacillus sphaericus on Anopheles arabiensis in Ethiopia. World J Microbiol Biotechnol 1997, 13:21-24.
• [26]Charles JF, Nielsen-LeRoux C: Mosquitocidal bacterial toxins: diversity, mode of action and resistance phenomena. Memorias Do Instituto Oswaldo Cruz 2000, 95:201-206.
• [27]Lago GM, Perez MC, Figueroa AM, Sonzalez FAC: Results of a pilot application of the biolarvicide Bacillus sphaericus to larval habitats of mosquitoes in Santa Cruz del Norte municipality (La Habana Province). Rev Cubana Med Trop 1991, 43:39-44.
• [28]Mulla MS, Su T, Thavara U, Tawatsin A, Ngamsuk W, Pan-Urai P: Efficacy of new formulations of the microbial larvicide Bacillus sphaericus against polluted water mosquitoes in Thailand. J Vector Ecology 1999, 24:99-110.
• [29]Appawu MA, Baffoe W, Afari A: Species composition and inversion polymorphism of the Anopheles gambiae complex in some sites of Ghana West Africa. Acta Trop 1994, 56:15-23.
• [30]Afari EA, Appawu M, Dunho S, Baffoe-Wilmot A: Malaria infection, morbidity and transmission in two ecological zones Southern Ghana. Afr J Health Sci 1995, 2:312-315.
• [31]Mulla MS, Darwaseh HA, Zgomba M: Effects of some environmental factors on the efficacy of Bacillus sphaericus 2362 and Bacillus thuringiensis (H-14) against mosquitoes. Bull Soc Vector Ecol 1990, 24:99-110.
• [32]Becker N: Community participation in the operational use of microbial control agents in mosquito control programmes. Bull Soc Vector Ecol 1992, 17:114-118.
• [33]Nayar JK, Knight JW, Ali A, Carlson DB, O’Bryan PD: Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensisserovar, Israelensis against two Florida mosquito species. J Am Mosq Control Assoc 1999, 15(Suppl 1):32-42.
• [34]Ohana B, Margalit J, Barak Z: Fate of Bacillus thuringiensis subsp. israelensis under Simulated Field Conditions. App Envt Microbiol 1987, 53(Suppl4):828-831.
• [35]Margalit J, Bobroglo H: The effect of organic materials and solids in water on the persistence of Bacillus thuringiensis var. israelensis Serotype H-14. Zeitschrift fur Angewandte Entomologie 1984, 97:516-520.
• [36]Tvedten S: The Best Control for Mosquitoes in The Best Pest Control 2. Intelligence pest management manual. 1997. http://www.thebestcontrol.com/chapter23/Mosquitoes-Part2.htm webcite. Accessed on 11 January 2012
• [37]Boisvert M: Utilization of Bacillus thuringiensis var. israelensis (Bti)-based formulation for the biological control of mosquito in Canada. In 6th Pacific Rim Con. Biotechnology of Bacillus thuringiensis and its Environmental Impacts. Edited by Cote JL, Otvos IS, Schwartz JI, Vincent C. Victoria, BC, Canada: Fairmont Empress Hotel; 2005:87-93.
• [38]Karch S, Manzambi ZA, Salaun JJ: Field trials with Vectolex (Bacillus sphaericus) and Vectobac (Bacillus thuringiensis (H-14) against Anopheles gambiae and Culex quinquefasciatus breeding in Zaire. J Am Mosq Control Assoc 1991, 7:176-179.
• [39]Das PK, Amalraj DD: Biological control of Malaria Vector. Ind J Med Res 1997, 106:174-197.